We assess patients with memory concerns,
including suspected mild cognitive impairment (MCI) or early-stage dementia.
The aim is to determine the likely cause of symptoms and whether further evaluation or treatment should be considered.
Symptoms we commonly see
- Progressive forgetfulness or repeating the same questions
- Difficulty managing daily activities (finances, medication, appointments)
- Word-finding difficulty or problems following conversations
- Getting lost in familiar places or confusion about time
- Changes in judgment, behavior, or personality noticed by family members
Sudden-onset confusion or new neurological symptoms (such as weakness, speech difficulty, or severe headache)
require urgent evaluation. In such cases, please contact the Emergency Department immediately.
At your visit
We review symptoms, medical history, and current medications, and perform a neurological examination.
Cognitive screening may be used when appropriate, and prior imaging or test results are reviewed.
The next step is determined based on clinical findings.
Not all patients require advanced imaging or specialized testing.
Testing is recommended only when clinically indicated.
Diagnostic workup and Alzheimer’s-related testing
Memory symptoms may have multiple causes, including Alzheimer’s disease, vascular changes,
medication effects, sleep disorders, mood disorders, and other neurological conditions.
Each case is assessed individually, and further testing is considered when appropriate.
Amyloid PET is not used as a general screening test.
It may be considered when clinically indicated, such as in suspected early Alzheimer’s disease.
See Alzheimer’s-related testing for details.
Treatment planning and next steps
After evaluation, we explain the likely diagnosis and outline a care plan.
This may include medication management, follow-up, and coordination with family members.
If further investigation or treatment is required, referral is arranged as appropriate.
If findings are consistent with early Alzheimer’s disease and criteria are met,
treatment options such as
Lecanemab (Leqembi®) or Donanemab (Kisunla®)
may be considered.
Appointment
Appointments are required in principle. A referral letter from another medical institution is recommended but not mandatory.
If you have prior records (MRI/CT reports, referral letter, medication list), please bring them.
It is also helpful if a family member can accompany the patient when possible.
For appointment requests and language support, please see the
Neurology page.